Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Signal-detected drugs for “Decreased Appetite” categorized by therapeutic categoryTherapeutic categoryNumber of drugsDrug nameTotalreportsOther hormone preparations (including antihormone preparations)6Dulaglutide (genetical recombination), tirzepatide, semaglutide (genetical recombination), osilodrostat phosphate, liraglutide (genetical recombination), mitotane138Anti-virus agents5Nirmatrelvir & ritonavir, ribavirin, amenamevir, glecaprevir hydrate & pibrentasvir, molnupiravir507Antiepileptics5Stiripentol, fenfluramine hydrochloride, rufinamide, topiramate, clobazam95Other biological preparations4Teceleukin (genetical recombination), interferon alfa (BALL-1), peginterferon alfa-2b (genetical recombination), interferon alpha (NAMALWA),385Agents affecting metabolism, n.e.c.4Pirfenidone, adalimumab (genetical resombination), nintedanib ethanesulfonate, anamorelin hydrochloride153Other agents affecting central nervous system4Riluzole, donepezil hydrochloride, memantine hydrochloride, rivastigmine146Opium alkaloids preparations3Morphine sulfate hydrate, hydromorphone hydrochloride, oxycodone hydrochloride hydrate92Antipyretics, analgesics and anti-inflammatory agents3Sulpiride hydrate & aminopropylone, tramadol hydrochloride, buprenorphine61Anti-tuberculous agents3Aluminoparaaminosalicylate calcium hydrate, ethionamide, delamanid27Antidotes2Calcium folinate, calcium levofolinate472Thyroid and para-thyroid hormone preparations1Teriparatide (genetical recombination)34Cardiotonics1Digoxin23Antidiabetic agents1Imeglimin hydrochloride21Purgatives and clysters1Lubiprostone18Antibiotic preparations acting mainly on acid-fast bacteria1Rifabutin17Other agents affecting digestive organs1Palonosetron hydrochloride12Antidiarrheals, intestinal regulators1Loperamide hydrochloride10Mineral preparations1Sodium ferrous citrate10Calcium compounds and preparations1Precipitated calcium carbonate & cholecalciferol & magnesium carbonate9Chinese meticines1Goshajinkigan7Antiparkinsonism agents1Levodopa & carbidopa hydrate & entacapone7Hypnotics and sedatives, antianxietics1Potassium bromide5Other cardiovascular agents1Ifenprodil tartrate5Psychotropic agents1Lisdexamfetamine mesilate4Diuretics1Acetazolamide sodium3Total542261

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Analysis of drug-induced adverse reactions affecting appetite and taste using the Japanese Adverse Drug Event Report Database

Study design awaiting verification · BMC Research Notes · 2026

Original publication title

Analysis of drug-induced adverse reactions affecting appetite and taste using the Japanese Adverse Drug Event Report Database

Mari Maese; Shingo Kondo; Yuka Sakatsume; Makoto Takagi; Yuta Yokoyama; Hiroki Iwata; Noriko Kobayashi; Katsunori Yamaura

© The Author(s) 2026

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

This study clarified drugs that may affect appetite and taste, providing a focused list for early detection. These findings may enhance pharmacovigilance practices and inform clinical approaches for managing drug-induced nutritional concerns.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

Pharmacotherapy is a potential risk factor for undernutrition; however, the association between individual drugs and nutrition-related adverse reactions remains unknown. We aimed to explore drugs affecting appetite and taste using the Japanese Adverse Drug Event Report (JADER) database.

Source: Objective

Abstract: What methods does the paper describe?

JADER reports (April 2004: January 2025) were analyzed for drug safety signals across seven Preferred Terms (PTs): “Appetite disorder,” “Decreased appetite,” “Abnormal loss of weight,” “Ageusia,” “Dysgeusia,” “Hypogeusia,” and “Taste disorder.” Signal detected drugs were classified by therapeutic category, and their package insert information was reviewed.

Source: Methods

Abstract: Results

Among 20,638 nutrition-related adverse reaction reports, signals were detected for 54, 14, 24, and 13 drugs for “Decreased appetite,” “Ageusia,” “Dysgeusia,” and “Taste disorder”, respectively. No signals were detected for the other three PTs. Regarding therapeutic category, other hormone preparations were common for “Decreased appetite,” while anti-viral agents were common for “Dysgeusia” and “Taste disorder.” Of these, five and 15 drugs lacked descriptions in the package inserts regarding decreased appetite and taste-related adverse reactions, respectively.

Source: Results

Abstract: Conclusions

This study clarified drugs that may affect appetite and taste, providing a focused list for early detection. These findings may enhance pharmacovigilance practices and inform clinical approaches for managing drug-induced nutritional concerns.

Source: Conclusions
Authors’ abstract

Objective

Pharmacotherapy is a potential risk factor for undernutrition; however, the association between individual drugs and nutrition-related adverse reactions remains unknown. We aimed to explore drugs affecting appetite and taste using the Japanese Adverse Drug Event Report (JADER) database.

Methods

JADER reports (April 2004: January 2025) were analyzed for drug safety signals across seven Preferred Terms (PTs): “Appetite disorder,” “Decreased appetite,” “Abnormal loss of weight,” “Ageusia,” “Dysgeusia,” “Hypogeusia,” and “Taste disorder.” Signal detected drugs were classified by therapeutic category, and their package insert information was reviewed.

Results

Among 20,638 nutrition-related adverse reaction reports, signals were detected for 54, 14, 24, and 13 drugs for “Decreased appetite,” “Ageusia,” “Dysgeusia,” and “Taste disorder”, respectively. No signals were detected for the other three PTs. Regarding therapeutic category, other hormone preparations were common for “Decreased appetite,” while anti-viral agents were common for “Dysgeusia” and “Taste disorder.” Of these, five and 15 drugs lacked descriptions in the package inserts regarding decreased appetite and taste-related adverse reactions, respectively.

Conclusions

This study clarified drugs that may affect appetite and taste, providing a focused list for early detection. These findings may enhance pharmacovigilance practices and inform clinical approaches for managing drug-induced nutritional concerns.

Supplementary Information

The online version contains supplementary material available at 10.1186/s13104-026-07734-5.

Publication and source details

Original title: Analysis of drug-induced adverse reactions affecting appetite and taste using the Japanese Adverse Drug Event Report Database

Mari Maese; Shingo Kondo; Yuka Sakatsume; Makoto Takagi; Yuta Yokoyama; Hiroki Iwata; Noriko Kobayashi; Katsunori Yamaura

BMC Research Notes · 2026

© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.JST SPRINGJPMJSP2123Maese Mari Keio University Doctorate Student Grant-in-Aid Program from Ushioda Memorial Fund

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T23:58:48.159942+00:00

DOI: 10.1186/s13104-026-07734-5 · PMC13032343